Literature DB >> 7703239

A new interpretation of the structure of the mycolyl-arabinogalactan complex of Mycobacterium tuberculosis as revealed through characterization of oligoglycosylalditol fragments by fast-atom bombardment mass spectrometry and 1H nuclear magnetic resonance spectroscopy.

G S Besra1, K H Khoo, M R McNeil, A Dell, H R Morris, P J Brennan.   

Abstract

Previous structural analysis of small oligosaccharide fragments had allowed the recognition of several small structural motifs within arabinogalactan, the dominant cell was structural polysaccharide of Mycobacterium tuberculosis. To determine how these motifs are connected to one another to form the complete polymer, oligosaccharide fragments containing up to 26 glycosyl residues were released by gentle acid hydrolysis of the per-O-methylated arabinogalactan, converted to fully per-O-alkylated oligoglycosylalditols, and purified by high-performance liquid chromatography, and the molecular weights and alkylation patterns of the resultant oligoglycosyl fragments were determined by fast atom bombardment mass spectrometry. The results, combined with previous studies, allowed further understanding of the intricate structural features of the nonreducing ends of arabinogalactan. Thus, the extended nonreducing ends of the arabinan were shown to consist of a tricosaarabinoside (23-mer). We reason that three such arabinan motifs are attached to the homogalactan component or arabinogalactan, which was previously shown to consist of alternating 5- and 6-linked beta-D-galactofuranosyl residues. Using the same approach as applied to the arabinan branches, an extended stretch of the galactan was isolated that consisted of at least 23 alternating beta-1,6 and beta-1,5 D-Galf residues, devoid of any branching, demonstrating that the points of attachment of the arabinan chains to galactan are close to the reducing end of galactan, which itself is linked to peptidoglycan via the linker disaccharide phosphate L-Rhap-(1-->3)-alpha-D-GlcNAc-P. By nuclear magnetic resonance analysis, the L-Rhap was shown to be in the alpha configuration. The long-chain alpha-alkyl-beta-hydroxy mycolic acids, known to occupy the 5-positions of both the terminal beta-D-Araf and internal 2-alpha-D-Araf residues of the terminal branched pentaarabinosyl motif, are now shown to be nonacylated at the beta-hydroxy function. Lack of acylation points to intramolecular hydrogen bonding between the beta-hydroxyl and carbonyl functions of the mycolic acid, providing a highly ordered arrangement of mycolic acids in accord with evolving models of the orientation of the cell wall polymers in mycobacterial cell walls. A revised model is proposed for the composition and orientation of the mycolyl-arabinogalactan in the cell walls of M. tuberculosis, which should increase our understanding of cell wall hydrophobicity, impermeability, and role in disease pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7703239     DOI: 10.1021/bi00013a015

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  58 in total

1.  Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosis.

Authors:  S V Ramaswamy; A G Amin; S Göksel; C E Stager; S J Dou; H El Sahly; S L Moghazeh; B N Kreiswirth; J M Musser
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

2.  Nucleotide polymorphism associated with ethambutol resistance in clinical isolates of Mycobacterium tuberculosis.

Authors:  S Srivastava; A Garg; A Ayyagari; K K Nyati; T N Dhole; S K Dwivedi
Journal:  Curr Microbiol       Date:  2006-09-12       Impact factor: 2.188

3.  Biosynthesis of diaminopimelate, the precursor of lysine and a component of peptidoglycan, is an essential function of Mycobacterium smegmatis.

Authors:  M S Pavelka; W R Jacobs
Journal:  J Bacteriol       Date:  1996-11       Impact factor: 3.490

4.  Novel mutations within the embB gene in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis.

Authors:  Ann S G Lee; Siti Noor Khadijah Othman; Yu Min Ho; Sin Yew Wong
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

Review 5.  Targeting the formation of the cell wall core of M. tuberculosis.

Authors:  Clifton E Barry; Dean C Crick; Michael R McNeil
Journal:  Infect Disord Drug Targets       Date:  2007-06

6.  Sequencing of oligoarabinosyl units released from mycobacterial arabinogalactan by endogenous arabinanase: identification of distinctive and novel structural motifs.

Authors:  Arwen Lee; Sz-Wei Wu; Michael S Scherman; Jordi B Torrelles; Delphi Chatterjee; Michael R McNeil; Kay-Hooi Khoo
Journal:  Biochemistry       Date:  2006-12-07       Impact factor: 3.162

7.  Galactosamine in walls of slow-growing mycobacteria.

Authors:  P Draper; K H Khoo; D Chatterjee; A Dell; H R Morris
Journal:  Biochem J       Date:  1997-10-15       Impact factor: 3.857

8.  Partial redundancy in the synthesis of the D-arabinose incorporated in the cell wall arabinan of Corynebacterineae.

Authors:  Xavier Meniche; Célia de Sousa-d'Auria; Bénoit Van-der-Rest; Suresh Bhamidi; Emilie Huc; Hairong Huang; Diane De Paepe; Marielle Tropis; Mike McNeil; Mamadou Daffé; Christine Houssin
Journal:  Microbiology       Date:  2008-08       Impact factor: 2.777

9.  Antigen 85C-mediated acyl-transfer between synthetic acyl donors and fragments of the arabinan.

Authors:  Aditya K Sanki; Julie Boucau; Donald R Ronning; Steven J Sucheck
Journal:  Glycoconj J       Date:  2008-12-04       Impact factor: 2.916

10.  Synthesis of deoxygenated alpha(1-->5)-linked arabinofuranose disaccharides as substrates and inhibitors of arabinosyltransferases of Mycobacterium tuberculosis.

Authors:  Ashish K Pathak; Vibha Pathak; William J Suling; James R Riordan; Sudagar S Gurcha; Gurdyal S Besra; Robert C Reynolds
Journal:  Bioorg Med Chem       Date:  2008-11-18       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.